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Abstract
Background: Early	palliative	care	team	consultation	has	been	shown	to	reduce	costs	
of hospital care. The objective of this study was to investigate the association be-
tween palliative care team (PCT) consultation and the content and costs of hospital 
care in patients with advanced cancer.
Material and Methods: A	 prospective,	 observational	 study	 was	 conducted	 in	 12	
Dutch	hospitals.	Patients	with	advanced	cancer	and	an	estimated	life	expectancy	of	
less than 1 year were included. We compared hospital care during 3 months of follow-
up for patients with and without PCT involvement. Propensity score matching was 
used	to	estimate	the	effect	of	PCTs	on	costs	of	hospital	care.	Additionally,	gamma	
regression models were estimated to assess predictors of hospital costs.
Results: We included 535 patients of whom 126 received PCT consultation. Patients 
with	 PCT	 had	 a	worse	 life	 expectancy	 (life	 expectancy	 <3	months:	 62%	 vs.	 31%,	
p	<	.01)	and	performance	status	(p	<	.01,	e.g.,	WHO	status	higher	than	2:54%	vs.	28%)	
and	more	often	had	no	more	options	for	anti-tumour	therapy	(57%	vs.	30%,	p	<	.01).	
Hospital	 length	 of	 stay,	 use	 of	most	 diagnostic	 procedures,	medication	 and	 other	
therapeutic	 interventions	were	 similar.	The	 total	mean	hospital	 costs	were	€8,393	
for	patients	with	and	€8,631	for	patients	without	PCT	consultation.	Analyses	using	
propensity scores to control for observed confounding showed no significant differ-
ence in hospital costs.
Conclusions: PCT consultation for patients with cancer in Dutch hospitals often oc-
curs	late	in	the	patients’	disease	trajectories,	which	might	explain	why	we	found	no	
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1  | INTRODUC TION
In patients with incurable diseases for whom death is approach-
ing,	 goals	 of	 care	 need	 to	 be	 realigned	 and	 typically	 include	 an	
emphasis on the relief of suffering and providing optimal quality 
of	 life	 (Sepulveda,	 Marlin,	 Yoshida,	 &	 Ullrich,	 2002).	 However,	
burdensome medical interventions are sometimes prolonged at 
the	end	of	life	without	any	improvement	in	these	outcomes	(Bolt,	
Pasman,	Willems,	&	Onwuteaka-Philipsen,	2016;	Hales	et	al.,	2014;	
McDermott	et	al.,	2017;	Teno	et	al.,	1997;	Veerbeek,	van	Zuylen,	
Swart,	van	der	Maas,	&	van	der	Heide,	2007).	Many	hospitals	have	
therefore started palliative care teams (PCTs) over the past decade 
(Brinkman-Stoppelenburg,	 Boddaert,	 Douma,	 &	 van	 der	 Heide,	
2016;	Davis,	Strasser,	&	Cherny,	2015;	Dumanovsky	et	al.,	2016).	
PCTs	 constitute	 of	 professionals	with	 expertise	 in	 palliative	 care	
and	can	be	consulted	by	physicians	or	nurses	working	in	the	hos-
pital.	Several	studies,	mainly	performed	in	the	United	States,	have	
shown that consultation of PCTs in hospitals is associated with 
better	patient	quality	of	life,	lower	symptom	burden	and	increased	
patient	 satisfaction	with	care	 (Gaertner	et	al.,	2017;	Kavalieratos	
et	al.,	2016;	Temel	et	al.,	2010;	Zimmermann	et	al.,	2014).	Studies,	
mostly	performed	in	the	United	States,	have	reported	that	the	in-
volvement of hospital PCTs was found to reduce the length of stay 
in	hospital	(Ciemins,	Blum,	Nunley,	Lasher,	&	Newman,	2007;	May	
et	al.,	2017)	and	to	improve	communication	about	goals	of	care,	re-
sulting	in	less	diagnostic	tests,	less	use	of	intensive	care	(Morrison	
et	 al.,	 2008;	Penrod	et	 al.,	 2006)	 and	 less	 aggressive	 care	during	
the	 last	weeks	of	 life	 (Temel	 et	 al.,	 2010).	Recently,	 a	meta-anal-
ysis showed that involvement of a PCT within 3 days after hos-
pital	admission	was	associated	with	significant	cost	savings	 (May,	
Normand,	et	al.,	2018).
In	 the	Netherlands,	health	care	 is	characterised	by	a	 strong	em-
phasis	on	home-based	care,	which	is	provided	by	general	practitioners	
and	community	nurses	(Kroneman	et	al.,	2016).	However,	77%	of	can-
cer	patients	of	65	years	and	older	in	the	Netherlands	were	found	to	
be admitted to the hospital at least once in the last 6 months of life 
(Bekelman	et	al.,	2016).	The	Dutch	Federation	of	Oncological	Societies	
has stated that every hospital providing oncology care should have a 
PCT	by	January	2017.	As	a	result,	many	Dutch	hospitals	have	now	es-
tablished	PCTs	(Brinkman-Stoppelenburg	et	al.,	2016).
We studied the association between PCT consultation and use of 
hospital care for patients with advanced cancer. We also estimated 
the costs of hospital care for patients with and without PCT consul-
tation,	while	taking	into	account	baseline	differences	between	both	
patient groups.
2  | MATERIAL AND METHODS
2.1 | Study design
We performed a prospective observational study in inpatient wards 
of	12	hospitals,	including	general,	teaching	and	university	hospitals.	
Nine	 hospitals	 had	 a	 PCT	 facility.	 Patients	with	 PCT	 consultation	
came from these nine hospitals. Patients without PCT consultation 
came from all twelve hospitals. Diagnostic and therapeutic inter-
ventions and hospital length of stay were compared for patients 
for whom a PCT was consulted during their stay in the hospital and 
control	 patients	 for	 whom	 no	 PCT	 was	 consulted.	 An	 extensive	
description of the study protocol has been published elsewhere 
(Brinkman-Stoppelenburg,	 Polinder,	 Vergouwe,	 &	 van	 der	 Heide,	
2015).
2.2 | Study population and setting
Patients	who	were	admitted	to	the	hospital	with	 incurable	cancer,	
who	were	18	years	or	over,	for	whom	the	physician	answered	“no”	to	
the	surprise	question	“Would	you	be	surprised	if	this	patient	would	
die	within	the	next	year?”	(Moss	et	al.,	2010)	and	who	were	expected	
to	stay	in	hospital	for	at	least	3	days	were	eligible	for	this	study.	No	
sample	size	was	calculated	a	priori	as	this	was	a	secondary	analysis	
of data from a study that had the primary aim to assess the effect of 
PCT consultation on patients’ quality of life. Patients were included 
sequentially	 (Brinkman-Stoppelenburg	 et	 al.,	 2015).	 All	 patients	
were followed during 3 months after their initial hospitalisation.
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2.3 | Intervention
PCTs	typically	assess	patients’	symptoms	and	physical,	emotional,	so-
cial	and	spiritual	problems	prioritize	these	and	provide	an	advice	to	
the attending healthcare professionals on how to address them. They 
also frequently advise on the coordination of care. Most PCTs consist 
of	clinicians	 from	different	specialties,	such	as	medical	oncologists,	
neurologists,	anesthesiologists,	and	nurses,	nurse	practitioners	and	
psychosocial	or	spiritual	caregivers	 (Brinkman-Stoppelenburg	et	al.,	
2016).	 Since	 2014,	 the	 Dutch	 Federation	 of	 Oncological	 Societies	
(SONCOS)	 has	 stated	 criteria	 for	 PCTs	 in	 their	 “Multidisciplinary	
standards	for	oncological	care	in	the	Netherlands”	(Dutch	Federation	
of	Oncological	Societies,	2017).	Criteria	 are	 for	 instance	 that	PCTs	
should	include	at	least	two	medical	specialist	and	a	nurse,	and	meet	
weekly.	Members	of	the	PCT	should	also	have	the	possibility	of	con-
sultation	of	other	disciplines,	all	with	expertise	in	palliative	care,	in	so	
far	as	not	already	part	of	the	PCT.	However,	it	is	known	from	other	
studies that PCTs in Dutch hospitals vary in the frequency of consul-
tations,	number	of	disciplines	that	are	represented	in	the	team	and	
the	 procedures	 for	 consultations	 (Brinkman-Stoppelenburg	 et	 al.,	
2016).
2.4 | Questionnaires and main outcomes
The	attending	medical	oncologist	was	asked	to	fill	in	a	questionnaire	
about	the	patient's	diagnosis,	WHO	performance	status,	co-morbid-
ity,	 treatment	 status	 and	 life	 expectancy.	 Life	 expectancy	was	 as-
sessed	using	 (modified	versions)	of	 the	Surprise	Question:	 “Would	
you	 be	 surprised	 if	 this	 patients	 died	 within	 12/6/3/1	month(s)?”	
(Moss	et	al.,	2010)	 Information	about	hospital	 length	of	stay,	diag-
nostic	 procedures,	 in-hospital	 treatments	 such	 as	 chemotherapy,	
invasive	 procedures,	 medication	 and	 intensive	 care	 days	 was	 ex-
tracted from the patients’ medical file over a 3 month period using a 
standardised	checklist.
2.5 | Costs
The economic evaluation was focused on hospital care. Costs of 
hospital care were calculated by multiplying volumes with the cor-
responding unit prices (see Attachment 1). We calculated costs of 
inpatient	days	in	the	hospital,	costs	of	diagnostic	procedures,	costs	
of	therapeutic	interventions,	including	chemotherapy,	medication	
and	 other	 types	 of	 treatment,	 and	 total	 hospital	 costs	 (May	 &	
Normand,	2016).	Unit	costs	for	medication	were	determined	with	
information	 from	the	National	Dutch	Formulary	 (National	Health	
Care	 Institute,	2016a,	2016b).	The	average	costs	per	day	 for	ex-
pensive	and	other	medications	were	calculated,	based	on	a	random	
sample of 43 patients with and 43 patients without PCT consulta-
tion.	Costs	for	 inpatient	days	in	hospitals	were	estimated	as	real,	
basic costs per day using detailed hospital administrative informa-
tion. We distinguished costs in general and university hospitals.
2.6 | Data analysis
Propensity score matching was used to adjust for possible con-
founders of the association of PCT consultation and costs of 
hospital	 care	 (Austin,	 2011).	Within	 propensity	 score	 matching,	
patients who received and did not receive PCT consultation are 
matched	 based	 on	 the	 propensity	 score,	which	 is	 the	 estimated	
probability that patients received PCT consultation based on their 
characteristics. Characteristics that were included in the propen-
sity	score	model	were	age,	gender,	prognosis,	WHO	performance	
status,	 planned	 or	 unplanned	 hospital	 admission,	 treatment	 sta-
tus,	 diagnosis,	 number	 of	 co-morbidities,	 type	 of	 hospital,	 time	
since primary diagnosis and number of hospital admissions. A 1:1 
matching was performed using the nearest-neighbour algorithm 
with a caliper width of 0.1. The matching was performed using the 
MatchIT	package	 in	R.	To	assess	 the	 impact	of	 the	caliper	width	
on	the	final	results,	we	performed	sensitivity	analyses	where	we	
varied the caliper width.
We fitted multivariable gamma regression models to inves-
tigate which determinants had a significant impact on hospital 
costs.	A	gamma	regression	model	was	used	due	to	the	expected	
skewed	 distribution	 of	 costs	 (Barber	 &	 Thompson,	 2004).	 The	
exponentiated	 regression	 coefficients	 from	 this	 model	 can	 be	
interpreted as the relative difference of average costs between 
patients.
Patient	 characteristics	 (age,	 gender,	 diagnosis	 and	 co-mor-
bidity)	and	prognostic	factors	such	as	WHO	performance	status,	
treatment	 status,	 type	 of	 hospitalisation,	 time	 since	 primary	 di-
agnosis and number of hospitalisations were selected as poten-
tial determinants. A p-value	 <	 .05	 was	 considered	 statistically	
significant.
Gamma	 regression	 models	 were	 estimated	 for	 total	 hospital	
costs,	costs	of	inpatient	hospital	stay,	costs	of	diagnostic	procedures	
and	 costs	 of	 therapeutic	 interventions.	 Each	 cost	model	 used	 the	
same variables.
Previous studies have found that the time between hospital ad-
mission and PCT consultation is an important factor in assessing the 
association between PCT consultation and hospital costs. We there-
fore also performed an analysis in which we restricted the consul-
tation	group	to	patients	 for	whom	consultations	took	place	within	
3 days of hospital admission.
2.7 | Ethical considerations
In	 three	 hospitals,	 data	 were	 collected	 anonymously.	 In	 nine	
other	 hospitals,	 the	 study	 included	 an	 assessment	 of	 patients’	
quality	of	life,	for	which	patients	provided	written	informed	con-
sent. The results of this study are reported elsewhere. The re-
search	protocol	was	submitted	to	the	Medical	Ethical	Research	
Committee	 of	 the	 Erasmus	 Medical	 Centre	 (MEC-2012–259).	
The committee stated that there were no objections to perform 
this study.
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TA B L E  1  Baseline	characteristics	of	patients	with	and	without	palliative	care	team	consultation
 
Patients with PCT consultation
n = 126
Patients without PCT consultation
n = 409
p-ValueMean (SD) Mean (SD)
Age 66.4 (12.5) 64.9 (11.6) .20a
	Number	of	hospital	admissions	due	to	current	disease	
(median,	IQR)
2	(1–3) 2	(1–4) .16b
	Time	since	diagnosis	(year,	median,	IQR) 2	(0–9) 1	(0–8) .29b
 N (%) N (%)  
Female	gender 73 (59) 215 (53) .22c
Type of hospital   <.01c
General	hospital 109 (86) 297 (73)  
Academic hospital 17 (14) 112 (27)  
Type of cancer   .49c
Gastrointestinal	cancer 52 (42) 172 (43)  
Urogenital	cancer 27 (22) 65 (16)  
Breast	cancer 17 (14) 48 (12)  
Lung	cancer 7 (6) 30 (8)  
Other 21 (17) 87 (22)  
Co-morbidities   .97c
No	co-morbidities 48 (38) 152 (37)  
1 co-morbidity 45 (36) 151 (37)  
> 1 co-morbidities 33 (26) 106 (26)  
Estimated	life	expectancy   <.01c
<	1	month 34 (27) 51 (13)  
1–3	months 44 (35) 73 (18)  
3–6	months 27 (21) 135 (33)  
6–12	months 21 (17) 150 (37)  
WHO performance status   <.01c
0 - Asymptomatic 9 (7) 67 (16)  
1-Symptomatic	but	completely	ambulatory 25 (20) 123 (30)  
2-Symptomatic,	<50%	in	bed	during	the	day 24 (19) 102 (25)  
3-Symptomatic,	>50%	in	bed,	but	not	bedbound 45 (36) 87 (21)  
4-Bedbound 22 (18) 29 (7)  
Hospital admission was:    
Planned 14 (12) 101 (26) <0.01c
Unplanned 107 (88) 293 (74)  
Treatment status at time of admission:   <0.01c
Patient received anti-tumour therapy 33 (26) 226 (56)  
No	further	options	for	anti-tumour	therapy 72 (57) 119 (30)  
Other 21 (17) 58 (14)  
at Test. 
bMann–Whitney	test.	
cChi-square test. 
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3  | RESULTS
3.1 | Baseline characteristics
Between	 January	 2013	 and	 February	 2015,	 535	 patients	were	 in-
cluded in the study. PCTs were consulted for 126 of these patients. 
Median time between hospital admission and PCT consultation 
was	4	days.	At	 the	 time	of	 their	 admission	 to	 the	hospital,	 62%	of	
patients	with	PCT	consultation	had	an	estimated	life	expectancy	of	
<3	months,	compared	to	31%	of	patients	without	PCT	consultation	
(p	<	 .01;	Table	1).	Hospitalisation	was	more	often	unplanned	 in	pa-
tients	with	PCT	consultation	(88%)	than	in	patients	without	PCT	con-
sultation	(74%;	p	<	.01).	Baseline	WHO	performance	status	was	also	
worse	for	patients	with	PCT	consultation:	54%	were	only	capable	of	
limited	self-care	or	completely	disabled,	compared	to	28%	of	patients	
without PCT consultation (p	<	 .01).	Furthermore,	 at	 admission,	pa-
tients with PCT consultation were less often receiving systemic anti-
tumour	treatment	than	patients	without	PCT	consultation	 (26%	vs.	
56%,	p	<	.01).
3.2 | Discharge destination and survival
Patients with PCT consultation were less often discharged to go 
home	than	patients	without	PCT	consultation	(62%	vs.	80%,	p	<	.01).	
There was a substantial difference in survival between the two 
groups	(Table	2):	72%	of	patients	with	PCT	consultation	did	not	sur-
vive	3	months	of	 follow-up,	 compared	 to	39%	of	patients	without	
PCT consultation.
3.3 | Hospital care
In	Table	3,	hospital	care	for	patients	with	and	without	PCT	consulta-
tion is presented. Patients with PCT consultation had a median length 
of	stay	in	the	hospital	of	11	days	(Interquartile	range	(IQR)	8–18),	com-
pared	to	9	days	(IQR	5–17)	for	patients	without	PCT	consultation.	The	
most common diagnostic procedures in both groups were blood tests 
(used	in	94%	of	patients	 in	both	groups),	X-rays	(used	in	52%	of	pa-
tients	with	and	50%	of	patients	without	PCT	consultation),	CT-scans	
(used	in	54%	and	39%,	respectively)	and	urine	tests	(used	in	42%	and	
28%	respectively).	Invasive	therapeutic	procedures	were	used	in	14%	
and	19%,	respectively,	and	chemotherapy	in	4%	and	20%	respectively.	
Other therapeutic interventions were rare in both groups.
3.4 | Costs of hospital care
The total mean costs of hospital care during 3 months of follow-
up	were	€8,393	for	patients	with	PCT	consultation	and	€8,631	for	
patients without PCT consultation (Table 3). The majority of these 
costs consisted of costs of inpatients days in the hospital.
Whereas the proportion of patients who survived the 3 month 
follow-up	period	was	lower	among	patients	with	PCT	consultation,	
we also calculated the average costs per in-hospital day. The average 
daily costs for diagnostic procedures were €54 in both groups. The 
average daily costs for therapeutic procedures were €83 and €201 
for	 patients	 with	 and	 without	 PCT	 consultation,	 respectively,	 for	
chemotherapy	they	were	€6	and	€131,	and	the	average	total	daily	
hospital costs were €607 and €757.
Analyses using propensity scores to control for observed con-
founding showed that PCT consultation had no effect on costs of 
hospital	 stay,	 costs	 of	 diagnostic	 procedures,	 costs	 of	 therapeutic	
interventions	or	 total	hospital	 costs.	Varying	 the	caliper	width	did	
not impact the results in a meaningful way.
3.5 | Predictors of costs of hospital care
Gamma	regression	models	showed	that	the	predictors	varied	between	
different types of costs (Table 4). The total costs of hospital care were 
predicted	by	patients’	prognosis:	a	prognosis	of	<1	month	was	associ-
ated with lower costs; and type of hospitalisation: unplanned admis-
sion was associated with lower costs. The total hospital care costs nor 
the costs per inpatient day were significantly associated with PCT 
consultation.
TA B L E  2   Discharge destination and survival of patients without and with palliative care team consultation
 
Patients with PCT consultation
N = 126
Patients without PCT consultation
N = 409
p-ValueN (%) N (%)
Discharge destination   <.01a
Home 78 (62) 318 (80)  
Hospice 13 (10) 15 (4)  
Other 16 (13) 42 (11)  
Deceased during hospital admission 18 (14) 25 (6)  
Survival
Deceased within 3 months after inclusion 91 (72) 160 (39) <.01a
aChi-square test. 
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3.6 | Early PCT consultation
A total of 63 patients received PCT consultation within the first 3 days 
of their hospital admission. The total mean costs of hospital care during 
3	months	of	follow-up	of	these	patients	were	€6,543.	Costs	for	inpa-
tient	days	were	€5,059,	and	costs	for	therapeutic	interventions	were	
€1,009.	 In	the	multivariable	analyses,	that	 included	51	patients	with	
and 357 patients without PCT consultation and adjusted for base-
line	differences,	we	found	a	non-significant	trend	of	 lower	costs	for	
TA B L E  3   Hospital care and costs during 3 months of follow-up in patients with and without PCT consultation
 
Patients with PCT consultation
N = 126
Patients without PCT consultation
N = 409
Length	of	hospital	stay	(days;	median,	IQR) 11	(8–18) 9	(5–17)
Number	of	hospital	admissions	(median,	IQR) 1	(1–1) 1	(1–2)
 N (%) N (%)
Diagnostic procedures
Ultrasound 27 (21) 90 (22)
MRI 19 (15) 43 (11)
CT-scan 68 (54) 161 (39)
Endoscopy 7 (6) 41 (10)
X-ray 66 (52) 204 (50)
ECG 17 (14) 44 (11)
Gastroscopy 3 (2) 21 (5)
Blood	test 119 (94) 384 (94)
Urine	test 53 (42) 113 (28)
Therapeutic interventions
Chemotherapy 5 (4) 80 (20)
Invasive procedures 18 (14) 79 (19)
Admission	to	ICU 0 (0) 11 (3)
Tube feeding 5 (4) 16 (4)
Artificial respiration 0 (0) 1 (0)
 Costs (€) Costs (€)
Costs of hospital stay
Mean (SD) 6,505	(4,546) 6,261	(6,263)
Median	(IQ) 5,136	(3,544–8,417) 4,494	(2,568–7,974)
Diagnostic costs
Mean (SD) 648 (656) 559 (726)
Median	(IQR) 455	(252–878) 374	(106–719)
Costs for therapeutic interventionsa
Mean (SD) 1,240	(2,351) 1812	(3,831)
Median	(IQR) 487	(414–726) 235	(103–2,529)
Costs for chemotherapy
Mean (SD) 119 (621) 856	(2,368)
Median	(IQR) 0	(0–0) 0	(0–0)
Total hospital costsb
Mean (SD) 8,393	(6,358) 8,631	(8,572)
Median	(IQR) 6,296	(4,444–10,483) 5,647	(3,445–10,826)
aCosts	for	therapeutic	interventions	include	medication	costs,	costs	for	other/medical	procedure	and	costs	of	PCT	consultation.	
bCosts	of	therapeutic	interventions	include	costs	of	PCT	consultation,	costs	of	therapeutic	procedures	and	medication	costs.	The	average	medication	
costs per day were estimated based on a random sample of 43 patients in both groups to be €15 per day for regular medication and €143 per day for 
expensive	medication.	We	did	not	find	a	difference	in	costs	between	patients	with	and	without	PCT	consultation.	
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inpatient hospital days (β	=	0.84,	p	=	.17),	diagnostics	(β	=	0.85,	p	=	.35),	
therapeutic interventions (β	=	0.80,	p = .33) and total hospital costs 
(β	=	0.84,	p = .15) for patients who received early PCT consultation.
4  | DISCUSSION
This is the first observational study to assess the association be-
tween PCT consultation and hospital care in Dutch hospitals. At 
baseline,	 patients	with	PCT	consultation	had	a	 significantly	worse	
prognosis and performance status. They also more often had an 
unplanned	hospitalisation,	which	probably	explains	why	they	more	
often received CT-scans and urine tests. Patients with PCT consulta-
tion also more often had no more options for anti-tumour therapy at 
admission,	which	explains	why	chemotherapy	during	follow-up	was	
less common in this group. We found no significant differences in 
hospital	length	of	stay,	medication	use,	ICU	admission,	tube	feeding	
or artificial respiration between patients who did and who did not 
receive	PCT	consultation.	When	controlling	for	baseline	differences,	
we did not find a statistically significant association between PCT 
consultation and hospital costs. When restricted to patients who 
received	PCT	within	3	days	of	hospital	admission,	we	also	found	a	
non-significant trend towards lower hospital costs for patients who 
received PCT consultation.
Other studies have reported that PCT involvement had a sig-
nificant impact on (costs of) hospital treatment of cancer patients 
(May,	 Normand,	 et	 al.,	 2018;	 May,	 Normand,	 &	 Morrison,	 2014).	
Most authors relate the impact of PCTs on medical treatment found 
in these studies to the core activities of PCTs. These include ade-
quate	controlling	of	symptoms,	initiating	patient	and	family-centred	
discussions	on	goals	of	care,	discussing	pros	and	cons	of	available	
treatment	 alternatives,	 and	 planning	 hospital	 discharge	 (Singer,	
Martin,	&	Kelner,	1999;	Steinhauser	et	al.,	2001).	PCT	involvement	
thus may account for a better match between patients’ needs and 
the	 treatment	provided,	 and	 thus	 involves	a	 shift	 in	 the	course	of	
treatment,	resulting	in	less	(aggressive)	hospital	treatment	(Morrison	
et	al.,	2008).	Consequently,	costs	are	saved.	In	a	meta-review	May	et	
al.	identified	10	studies	until	2013,	all	performed	in	the	United	States	
that assessed costs and cost-effectiveness of specialist inpatient pal-
liative care consultation in acute care hospitals. The review showed 
“a	clear	pattern	of	cost	savings”	from	inpatient	palliative	care	teams,	
with	savings	ranging	from	9%	to	25%	(May	et	al.,	2014).	Further,	a	
cost analysis of early palliative care in 151 patients with metastatic 
lung cancer showed a non-significant trend towards lower total 
costs	of	hospital	care	per	day	and	significantly	 lower	expenses	for	
chemotherapy	 (Greer	 et	 al.,	 2016).	 Recently,	 a	 meta-analysis	 was	
performed to estimate the association of PCT consultation within 
3	days	of	hospital	 admission	with	 total	 direct	hospital	 costs	 (May,	
Normand,	et	al.,	2018).	It	was	found	that	PCT	consultation	was	asso-
ciated	with	significant	costs	savings	(on	average	€4,151	per	hospital	
admission)	for	patients	with	cancer.	Savings	were	higher	for	patients	
with	 more	 co-morbidities	 (May,	 Normand,	 et	 al.,	 2018)	 and	 were	
mainly	due	to	a	reduced	length	of	stay,	less	ICU	admissions,	and	less	
medication	and	laboratory	costs	(May	et	al.,	2015;	May,	Garrido,	et	
al.,	2018;	Morrison	et	al.,	2008;	Penrod	et	al.,	2010).
There may be several reasons why we did not find a significant 
effect	of	PCT	consultation	on	costs	of	hospital	care.	First,	there	is	an	
open culture towards death and end-of-life care and relatively strong 
and	long-standing	emphasis	on	home-based	care	in	the	Netherlands	
as	 compared	 with	 other	 countries	 (Kroneman	 et	 al.,	 2016;	 Leget,	
2017).	Bekelman	et	al.	found	hospital	costs	in	the	last	180	days	of	
life	of	patients	with	cancer	to	be	much	higher	in	the	United	States	
than	 in	 the	Netherlands,	where	 fewer	patients	are	admitted	 to	an	
ICU	and	fewer	patients	 receive	chemotherapy	 in	 the	 last	phase	of	
life	(Bekelman	et	al.,	2016).	Second,	it	has	been	suggested	that	cost	
analyses should incorporate the timing of the intervention (May & 
Normand,	2016).	An	earlier	intervention	may	involve	larger	cost	sav-
ings	 (May	&	Normand,	 2016).	 This	 finding	 seems	 to	be	 confirmed	
by	our	study,	as	total	costs	were	lower	for	patients	with	(early)	PCT	
consultation,	although	our	findings	were	not	statistically	significant.	
Third,	 we	 included	 patients’	 prognosis	 as	 a	 potential	 confounder,	
because many studies have shown that PCT consultation often 
concerns	patients	with	a	limited	life	expectancy	which	may	in	itself	
affect	the	use	of	hospital	care.	This	is,	however,	not	commonly	done	
in	other	studies	(May,	Normand,	et	al.,	2018).
Our	study	has	several	limitations.	First,	we	only	studied	hospital	
care. A health care or societal perspective would have given a more 
comprehensive insight in the potential impact of PCT consultation 
(May	et	al.,	2014).	Second,	although	we	corrected	for	known	possi-
ble	confounders,	there	may	have	been	additional	unmeasured	con-
founding	factors,	such	as	the	presence	of	other	activities	to	improve	
hospital	palliative	care,	or	the	experience	and	knowledge	about	pal-
liative	care	of	general	caregivers.	Furthermore,	no	sample	size	cal-
culation	was	made	a	priori,	which	may	account	 for	non-significant	
results	as	the	sample,	especially	in	the	analysis	of	early	versus	later	
consultation,	is	small	for	this	kind	of	study.
5  | CONCLUSION
When	 taking	confounding	by	 indication	 into	account,	 involvement	
of a PCT was not significantly associated with a reduction in costs 
of hospital care. We found that PCT consultation in Dutch hospitals 
often	occurs	late	in	patients’	disease	trajectories.	This	might	explain	
why we found no effect of PCT consultation on costs of hospital 
care.	 When	 PCT	 consultations	 occurred	 early	 during	 admission,	
costs of hospital care are lower for patients with than patients with-
out	PCT	consultation.	Earlier	consultation	could	be	beneficial	to	pa-
tients and reduce costs of care.
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